argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025 October 3, 2025 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Extraordinary General Meeting of shareholders will be held at 14:00 CET on Tuesday, November 18, 2025 at the offices of Freshfields LLP (Netherlands), Strawinskylaan 10, 1077 XZ Amsterdam, the Netherlands.The shareholders and all other persons with meeting rights are invited to attend the E...
JDE Peet’s calls for coffee industry to implement Regenerative Agriculture Coffee Roadmap to boost coffee supply chain resilience Call to action comes as company marks 10 years of its leading Common Grounds farmer programmes PRESS RELEASE Amsterdam, October 1, 2025 This International Coffee Day, JDE Peet’s (EURONEXT: JDEP) celebrates ten years of its pioneering Common Grounds farmer programmes and calls on the coffee industry to urgently implement the , securing the future of coffee. The call to action comes as global coffee supplies have been hit by worsening climate conditions, includi...
JDE Peet’s transfers shares and grants awards to participants under its employee incentive plans PRESS RELEASEAmsterdam, September 25, 2025This is a press release by JDE Peet’s N.V. (JDE Peet’s or the Company) pursuant to the provisions of section 5, paragraph 4 and section 6, paragraph 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) in connection with the recommended public offer by Keurig Dr Pepper, Inc. (the Offeror) for all the issued and outstanding shares in the capital of JDE Peet’s (the Offer). This press release does not constitute an offer, or any so...
Update on intended recommended public offer by KDP for JDE Peet's Burlington, Mass., Frisco, Texas and Amsterdam, the Netherlands, 19 September 2025 – This is a joint press release by Keurig Dr Pepper Inc. (NASDAQ: KDP) (''KDP'') and JDE Peet's N.V. (EURONEXT: JDEP) ("JDE Peet's"). This joint press release is issued pursuant to the provisions of Section 7, paragraph 1 sub a of the Dutch Decree on public takeover bids (Besluit openbare biedingen Wft) (the "Decree") in connection with the intended recommended public offer by KDP for all the issued and outstanding ordinary shares in the ca...
JDE Peet’s transfers shares to participants under its employee incentive plans PRESS RELEASEAmsterdam, September 15, 2025 This is a press release by JDE Peet’s N.V. (JDE Peet’s or the Company) pursuant to the provisions of section 5, paragraph 4 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) in connection with the recommended public offer by Keurig Dr Pepper, Inc. (the Offeror) for all the issued and outstanding shares in the capital of JDE Peet’s (the Offer). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscr...
Two Directors at Argen X SE sold 10,608 shares at between 609.000EUR and 610.600EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
JDE Peet’s share buyback update PRESS RELEASEAmsterdam, September 1, 2025 JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee company, today announced that it has not repurchased any shares in the period from August 25, 2025 up to and including August 29, 2025. The company has also decided to terminate its share buyback program, effective immediately. Under the program, a total of 5,477,094 ordinary shares were repurchased at an average price of EUR 20.73, and for a total consideration of EUR 113.5 million. This press release is issued in accordance with the disclosure a...
argenx to Present at Upcoming Investor Conferences August 28, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA.Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET i...
1H25 revenues landed at €6.5m growing 12% y/y (26% h/h) below our €8mE. Gross margins kept up well at a high 60%. Ongoing cost efficiencies show off with FTE's down to 154 vs. 169 at year end. EBITDA stood at €-8.2m (vs. €-6.4m in 1H24 and our €-6.9mE). Guidance remained unchanged calling for FY25 revenues to grow in the 50-70% range. We are currently at the mid point of this range. In order to reach this forecast, 2H25 revenues should grow >115% y/y and >70% sequentially (h/h). We remain cautio...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.